The global “COVID-19 diagnostics market size” is projected to reach USD 11.40 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period. Uncontrolled spread of the coronavirus worldwide will be the major factor propelling the growth of this market, shares Fortune Business Insights™ in its report, titled “COVID-19 Diagnostics Market Size, Share & Industry Analysis, By Product (Instruments and Reagents & Kits), By Technology (PCR (Polymerase Chain Reaction), ELISA (Enzyme-linked Immunosorbent Assay), Point-of-care (POC), and Others), By Sample Type (Oropharyngeal and Nasopharyngeal Swabs, Blood, Urine, and Others), By End User (Hospitals & Clinics, Laboratories & Diagnostic Centers, and Research Institutes), and Regional Forecast, 2020-2027”.

According to Johns Hopkins University, global COVID-19 infections reached 100,000 in just 60 days, growing to 200,000 in the next 12-14 days, and the recent addition of 100,000 cases has taken only 3 days. The report provides market analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

Key Companies and Manufacturers Covered:

• PerkinElmer Inc.
• Quest Diagnostics Incorporated
• Quidel Corporation
• Siemens Healthcare GmbH
• Abbott
• Thermo Fisher Scientific Inc.
• bioMérieux SA
• Hoffmann-La Roche Ltd
• Danaher Corporation

Concerted Efforts towards Developing COVID Detection Tests to Accelerate Growth

With the COVID-19 pandemic showing no signs of abatement, medical and regulatory bodies are collaborating to encourage innovation and speed up research in developing coronavirus detection tools. For instance, in April 2020, the National Institutes of Health in the US announced the launch of Rapid Acceleration of Diagnostics (RADx) initiative with a funding of USD 1.5 billion to commercialize and widen the accessibility of COVID-19 testing. Similarly, in June 2020, the US Food and Drug Administration (FDA) joined the COVID-19 Diagnostics Evidence Accelerator created by the Friends of Cancer Research and Reagan-Udall Foundation with the aim to evaluate the performance of PCR and antibody tests for COVID. Together, these and similar initiatives are expected to augment the COVID-19 diagnostics market growth throughout 2020.

High Number of COVID-19 Cases to Give North America Leading Market Position

The United States is one of the worst-hit countries in the world by the coronavirus pandemic, with the number of cases as of June 2020 standing at 2.68 million and 129,000 deaths. In response, the US government is injecting more funds into medical research facilities to accelerate development of COVID-19 diagnostics and widen the testing net in the country. The region’s market size in 2019 stood at USD 2.17 billion. In Europe, the virus is spreading at a furious pace, with the UK, Italy, Spain, France, and Germany having the highest number of cases. Quick adoption of advanced detection tools in the region will enable it to expand its footprint in the COVID-19 diagnostics market share in the immediate future. Heavy investments by governments in Asia Pacific in the healthcare sector are expected to favor market growth in the region.

Detailed Table of Content:

• Introduction
  • Market Scope
  • Market Segmentation
  • Market Methodology
  • Definitions and Assumptions
• Executive Summary
• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
• Key Insights
  • Overview: Guidelines for COVID-19 Diagnosis
  • New Product Launch
  • Prevalence of COVID-19 Disease
  • Key Industry Developments – Mergers, Acquisitions, and Partnerships 

• Global COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2016-2027
  • Key Findings / Summary
  • Market Analysis, Insights and Forecast – By Product
    • Instruments
    • Reagents & Kits
  • Market Analysis, Insights and Forecast – By Technology
    • Polymerase Chain Reaction (PCR)
    • Enzyme-linked Immunosorbent Assay (ELISA)
    • Point-of-care (POC)
    • Others
  • Market Analysis, Insights and Forecast – By Sample Type
    • Oropharyngeal & Nasopharyngeal Swabs
    • Blood
    • Urine
    • Others
  • Market Analysis, Insights and Forecast – By End User
    • Hospitals & Clinics
    • Laboratories & Diagnostic Centers
    • Research Institute
  • Market Analysis, Insights and Forecast – By Geography
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

TOC Continued….

https://www.medgadget.com/2020/08/covid-19-diagnostics-market-2020-glob…